Morgan Stanley Nexgel, Inc. Transaction History
Morgan Stanley
- $1.59 Trillion
- Q3 2025
A detailed history of Morgan Stanley transactions in Nexgel, Inc. stock. As of the latest transaction made, Morgan Stanley holds 87,104 shares of NXGL stock, worth $166,368. This represents 0.0% of its overall portfolio holdings.
Number of Shares
87,104
Previous 121,554
28.34%
Holding current value
$166,368
Previous $313,000
32.27%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding NXGL
# of Institutions
19Shares Held
566KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA124KShares$236,0930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA66.4KShares$126,7640.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny63.5KShares$121,1930.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA43.6KShares$83,3250.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA38KShares$72,6040.02% of portfolio
About NEXGEL, INC.
- Ticker NXGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 5,572,230
- Market Cap $10.6M
- Description
- NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. NEXGEL, Inc. was...